Haemonetics (HAE) Non-Current Debt (2010 - 2026)

Haemonetics has reported Non-Current Debt for 17 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt rose 32.38% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 32.38% YoY), and the FY2026 full-year result was $1.2 billion, up 32.38% from the prior year.
• Non-Current Debt for Q1 2026 stood at $1.2 billion, up from $920.0 million in the prior quarter.
• The five-year high for Non-Current Debt was $1.2 billion in Q4 2024, with the low at $559.4 million in Q2 2022.
• Average Non-Current Debt over 5 years is $885.6 million, with a median of $827.2 million recorded in 2023.
• Year-over-year, Non-Current Debt jumped 116.29% in 2022 and fell 24.58% in 2025.
• Tracing HAE's Non-Current Debt over 5 years: stood at $756.8 million in 2022, then rose by 13.22% to $856.8 million in 2023, then surged by 42.35% to $1.2 billion in 2024, then slipped by 24.58% to $920.0 million in 2025, then jumped by 32.56% to $1.2 billion in 2026.
• The last three Non-Current Debt figures came in at $1.2 billion (Q1 2026), $920.0 million (Q4 2025), and $920.4 million (Q3 2025), per Business Quant data.

Peer Comparison